Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

8.520 -0.090 (-1.05%)
Streaming Delayed Price Updated: 3:27 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Psychedelic Stock Gainers And Losers From February 8, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
Via Benzinga
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
7 Tempting Sin Stocks to Buy for Promising Profits
After a rough time in 2022, investors may want to consider sin stocks to buy for a cynical shot at significant upside potential. 
Via InvestorPlace
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions
(Part one of a three-part series) 
Via Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. 
Via InvestorPlace
6 Largest Psychedelic Stocks Down 3% This Week
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Via Benzinga
The "Rags-To-Riches" Portfolio Update: Week Ending January 27
The Rags-to-Riches Portfolio tracks the performance of 14 cannabis, psychedelic and plant-based food stocks constituent . Here, performances last week and year-to-date. 
Via Talk Markets
Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission. 
Via Benzinga
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. 
Via Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
Via Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
Via Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
Via Benzinga
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different... 
Via Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
Via Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before... 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On?
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday. 
Via Benzinga
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances
Once considered the realm of ancient civilizations and countercultures, psychedelics have in the past few years been seeing increasing interest.  
Via Benzinga
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.